Introduction: Whole blood donation is generally considered to be a safe procedure, but occasionally adverse reactions of varying severity may occur during or at the end of the collection. The aim of this study is to analyze the frequency and type of immediate adverse reactions occurring in whole blood donation. Material and methods: This was a record-based study conducted on all immediate adverse reactions related to whole blood donation performed over 36 months, from January 2019 to December 2021. After obtaining consent, donors were asked to complete a pre-donation questionnaire that gathered information on demographics and blood donation history. All donations were performed using 16-gauge needles from veins in the antecubital area after maintaining strict asepsis of venipuncture site. Blood collection was performed by trained technologists. Each donor was observed before, during and after donation for the occurrence of any adverse reactions. All reactions observed immediately after donation were recorded. Results: Overall, 168 adverse reactions were reported in relation to the 32,002 donations, resulting in an overall adverse reaction rate of 0.52%, that is, an incidence of 1 in every 191 donations. Majority of donors who experienced adverse effects were in age group of 18-25 years (66, 39.3%). First time donors had higher frequency (61,36.30%) for reactions. Vasovagal reaction of mild intensity was the most observed adverse reaction and accounted for approximately 72% of all adverse reactions noted. None of the donors with adverse reactions necessitated hospitalization. Conclusion: The risk of complications related to blood donation is low. Analysis of blood donation-related adverse events enables identification of at-risk donors and supports the implementation of targeted motivational strategies, effective predication counseling and optimized care during and after blood donation. Pulse Volume 17, Issue 2 2025; 15-19
| Mualliflar | Tamanna Afroz, Farabi Ahmed, Abu Jafar Mohammed Saleh |
|---|---|
| Jurnal | PULSE |
| Nashr sanasi | 2026-05-19 |
| Jild | 17 |
| Son | 2 |
| Betlar | 15-19 |
| DOI | 10.3329/pulse.v17i2.89954 |
DOI: 10.3329/pulse.v17i2.89954 · Maqolaning asl sahifasi
Introduction: The cardio-ankle vascular index (CAVI) is a noninvasive indicator used to assess arterial stiffness and predict atherosclerotic cardiovascular disease (ASCVD). CAVI represents a scale-converted form of the…
Background: Anaemia is a serious public health concern all over the world. It is a huge health burden for low and middle-income countries. Reproductive-age women, especially pregnant women, suffer a lot due to this…
Introduction: DLL4-NOTCH1 signaling mediates juxtacrine communication between tip- and stalk-like endothelial cells during vascular sprouting, contributing to complementary aspects of endothelial function. Thus…
Background: Peritoneal inflammatory nodules are rare, non-neoplastic lesions that can be associated with endometrioid carcinoma of the uterus. Grossly, these lesions may closely resemble peritoneal carcinomatosis…
Introduction: Arterial stiffness, measured by brachial-ankle pulse wave velocity (baPWV), has been linked to diabetic peripheral neuropathy (DPN). However, the evidence regarding its association with large-nerve fiber…
Background: Carotid body tumors (CBTs) are rare, highly vascular neuroendocrine tumors originating from paraganglionic cells in the carotid bifurcation. Case Presentation: We report the case of a 21-years-young female…
Methods and techniques for assessing out-of-office blood pressure (20'+5')
Laryngeal cancer is the second most common type of head & neck malignancies. This cancer commonly spreads to regional lymph nodes and distant metastasis is rare. Liver metastasis rarely occurs without evidence of lung…
In an ageing population, degenerative aortic stenosis (AS) and elevated arterial stiffness frequently coexist, imposing a combined valvular and pulsatile arterial afterload on the left ventricle (LV). Since the…
The coexistence of beta thalassemia trait (also known as heterozygous beta thalassemia, HBT) and polycythemia vera (PV) is extremely rare, with only a few cases reported in medical literature. This combined condition is…